Factor IX, Activity
Ordering Recommendation
Order to diagnose factor IX deficiency (hemophilia B) and monitor factor IX replacement therapy.
New York DOH Approval Status
Specimen Required
Lt. blue (sodium citrate). Refer to Specimen Handling at aruplab.com for hemostasis/thrombosis specimen handling guidelines.
Transfer 2 mL platelet-poor plasma to an ARUP Standard Transport Tube. (Min: 1 mL)
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.
Serum. EDTA plasma, clotted or hemolyzed specimens.
Ambient: 4 hours; Refrigerated: Unacceptable; Frozen: 2 weeks
Methodology
Electromagnetic Mechanical Clot Detection
Performed
Mon-Sat
Reported
1-3 days
Reference Interval
Age | Reference Interval | Age | Reference Interval |
---|---|---|---|
1-4 days | 15-91% | 7-9 years | 70-133% |
5-29 days | 15-91% | 10-11 years | 72-149% |
30-89 days | 21-81% | 12-13 years | 73-152% |
90-179 days | 21-113% | 14-15 years | 80-161% |
180-364 days | 36-136% | 16-17 years | 86-176% |
1-5 years | 47-104% | 18 years and older | 78-184% |
6 years | 63-89% |
Interpretive Data
Standard
Note
Hotline History
CPT Codes
85250
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0030100 | Factor IX, Activity | 3187-2 |
Aliases
- Antihemophilic Factor B
- Christmas Factor
- Coagulation Factor IX Activity Assay, Plasma
- Intrinsic Factor Proteins
- Intrinsic Factors
- Plasma Thromboplastin Component
- PTC